CytomX Therapeutics Inc (CTMX)

NASDAQ
1.530
-0.060(-3.77%)
Pre Market
1.480
-0.050(-3.27%)
- Real-time Data
  • Volume:
    1,448,557
  • Day's Range:
    1.515 - 1.625
  • 52 wk Range:
    1.190 - 7.530

CTMX Overview

Prev. Close
1.59
Day's Range
1.515-1.625
Revenue
72.62M
Open
1.6
52 wk Range
1.19-7.53
EPS
-1.48
Volume
1,448,557
Market Cap
100.9M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,856,738
P/E Ratio
-1.12
Beta
0.485
1-Year Change
-68.65%
Shares Outstanding
65,950,242
Next Earnings Date
Nov 08, 2022
What is your sentiment on CytomX Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

CytomX Therapeutics Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

CytomX Therapeutics Inc Analysis

CytomX Therapeutics Inc Company Profile

CytomX Therapeutics Inc Company Profile

Employees
145

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is developing a class of investigational conditionally activated therapeutics, based on its Probody technology platform, for the treatment of cancer. Its Probody technology platform is designed to enable conditional activation of antibody-based drugs in the tumor microenvironment while minimizing drug activity in healthy tissues and in circulation. The Company's product candidates include the conditionally activated antibody-drug conjugates (ADCs) praluzatamab ravtansine (CX2009, targeting CD166) and CX-2029, targeting CD71, and the Probody immune checkpoint inhibitors pacmilimab (CX-072, targeting PD-L1) and BMS-986249 (targeting CTLA-4). It also has two preclinical agents in investigational new drug (IND)-enabling studies - a conditionally activated ADC targeting EpCAM/Trop-1 (CX-2043) and a conditionally activated T-cell engaging bispecific antibody targeting EGFR and CD3 (CX-904).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellStrong SellStrong SellBuyStrong Sell
SummarySellStrong SellStrong SellNeutralStrong Sell
  • fair value = 0.7dollar/share
    0
    • drop it as much as u can lol
      0
      • Only going up from here -
        0